Literature DB >> 18181886

Organization-based performance measures of cancer care quality: core measure development for breast cancer in Taiwan.

K-P Chung1, M-S Lai, S H Cheng, S-T Tang, C C Huang, A-L Cheng, P-C Hsieh.   

Abstract

The purpose of the study was to develop organization-based core performance measures (CPMs) for breast cancer patients treated in hospitals that participated in cancer quality improvement programmes in Taiwan. CPMs were developed in three stages that included a preparation, a consensus building stage, and two stages of stakeholder feedback. Three criteria and seven subcriteria were applied in the development process. Indicators listed in a Delphi questionnaire were based on a literature search, indicators developed by relevant institutions and discussion by authors. Each indicator needed to meet inclusion criteria as a final indicator. Evidence-based guidelines, expert opinions from panel group, 27 hospitals and empirical data were all applied to develop and revise the core measures. Fifteen out of 28 indicators were selected and modified after the three stages. There were two pre-treatment indicators for screening and diagnosis, nine treatment-related indicators, and four monitoring-related indicators. Six indicators were supported by evidence level I, and four indicators by level II evidence. The CPMs for breast cancer can be developed systematically and be applied for internal quality improvement and external surveillance. Our experience can be extended to other cancer sites and adapted to link with pay for performance or certification program in cancer care.

Entities:  

Mesh:

Year:  2008        PMID: 18181886     DOI: 10.1111/j.1365-2354.2007.00796.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  A Delphi study to develop indicators of cancer patient experience for quality improvement.

Authors:  Kathryn E Williams; Janet Sansoni; Darcy Morris; Cristina Thompson
Journal:  Support Care Cancer       Date:  2017-07-15       Impact factor: 3.603

2.  Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan.

Authors:  Raymond N C Kuo; Kuo-Piao Chung; Mei-Shu Lai
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

3.  Re-examining the significance of surgical volume to breast cancer survival and recurrence versus process quality of care in Taiwan.

Authors:  Raymond N Kuo; Kuo-Piao Chung; Mei-Shu Lai
Journal:  Health Serv Res       Date:  2012-06-07       Impact factor: 3.402

4.  Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan.

Authors:  Kuo-Piao Chung; Yun-Jau Chang; Mei-Shu Lai; Raymond Nien-Chen Kuo; Skye H Cheng; Li-Tzong Chen; Reiping Tang; Tsang-Wu Liu; Ming-Jium Shieh
Journal:  BMC Health Serv Res       Date:  2010-01-27       Impact factor: 2.655

5.  Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.

Authors:  Ming-Liang Jin; Yue Gong; Yu-Cheng Pei; Peng Ji; Xin Hu; Zhi-Ming Shao
Journal:  Breast       Date:  2019-11-14       Impact factor: 4.380

6.  Quality indicators for responsible use of medicines: a systematic review.

Authors:  Kenji Fujita; Rebekah J Moles; Timothy F Chen
Journal:  BMJ Open       Date:  2018-07-16       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.